Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America. Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishm...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/8629039 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832546089265266688 |
---|---|
author | Pashupati Pokharel Rakesh Ghimire Pratik Lamichhane |
author_facet | Pashupati Pokharel Rakesh Ghimire Pratik Lamichhane |
author_sort | Pashupati Pokharel |
collection | DOAJ |
description | Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America. Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishmaniasis. Despite limited therapies for visceral leishmaniasis and emerging drug resistance, a proper review on the action of paromomycin for kala-azar is lacking. This systematic review aims to look for the efficacy and safety aspects of paromomycin for the treatment of visceral leishmaniasis. |
format | Article |
id | doaj-art-d4f79bf12b2f4ee9ada3b94a53c4cecb |
institution | Kabale University |
issn | 1687-9686 1687-9694 |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Tropical Medicine |
spelling | doaj-art-d4f79bf12b2f4ee9ada3b94a53c4cecb2025-02-03T07:23:56ZengWileyJournal of Tropical Medicine1687-96861687-96942021-01-01202110.1155/2021/86290398629039Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic ReviewPashupati Pokharel0Rakesh Ghimire1Pratik Lamichhane2Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NepalDepartment of Clinical Pharmacology, Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, NepalMaharajgunj Medical Campus, Institute of Medicine, Kathmandu, NepalVisceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America. Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishmaniasis. Despite limited therapies for visceral leishmaniasis and emerging drug resistance, a proper review on the action of paromomycin for kala-azar is lacking. This systematic review aims to look for the efficacy and safety aspects of paromomycin for the treatment of visceral leishmaniasis.http://dx.doi.org/10.1155/2021/8629039 |
spellingShingle | Pashupati Pokharel Rakesh Ghimire Pratik Lamichhane Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review Journal of Tropical Medicine |
title | Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review |
title_full | Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review |
title_fullStr | Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review |
title_full_unstemmed | Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review |
title_short | Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review |
title_sort | efficacy and safety of paromomycin for visceral leishmaniasis a systematic review |
url | http://dx.doi.org/10.1155/2021/8629039 |
work_keys_str_mv | AT pashupatipokharel efficacyandsafetyofparomomycinforvisceralleishmaniasisasystematicreview AT rakeshghimire efficacyandsafetyofparomomycinforvisceralleishmaniasisasystematicreview AT pratiklamichhane efficacyandsafetyofparomomycinforvisceralleishmaniasisasystematicreview |